Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Clinical outcomes with established injectable GLP-1 receptor agonists are well-documented
Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S (2016) Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and Meta-analysis
The effects of GLP-1 RAs on obesity are not solely due to weight loss, but some pleiotropic effects like decreased inflammation, oxidative stress, and fibrosis also play a role in some of the complications
Emotional eating is the tendency to eat in response to feelings such as stress, sadness, or boredom
Ongoing tirzepatide studies in obesity Lillys SURMOUNT-2 trial, estimated to read out in 2H 2023 , will assess weight loss in patients with T2D
US$ 24.78
US$ 29.30
US$ 24.28
US$ 27.36
US$ 23.46
US$ 23.42
US$ 20.91
US$ 26.65
